statistiche ricercatore

Continente	#
NA - Nord America	1.317
EU - Europa	1.131
AS - Asia	632
SA - Sud America	71
AF - Africa	16
OC - Oceania	9
Continente sconosciuto - Info sul continente non disponibili	2
Totale	3.178

Nazione	#
US - Stati Uniti d'America	1.288
PL - Polonia	431
IT - Italia	285
SG - Singapore	231
CN - Cina	137
DE - Germania	79
VN - Vietnam	78
SE - Svezia	67
BR - Brasile	57
FR - Francia	47
HK - Hong Kong	45
FI - Finlandia	37
GB - Regno Unito	32
IN - India	30
KR - Corea	30
NL - Olanda	29
UA - Ucraina	27
RU - Federazione Russa	23
CA - Canada	19
TR - Turchia	17
BE - Belgio	14
JP - Giappone	14
CZ - Repubblica Ceca	12
IE - Irlanda	12
BG - Bulgaria	10
BD - Bangladesh	7
IR - Iran	7
MA - Marocco	6
NZ - Nuova Zelanda	6
CH - Svizzera	5
ES - Italia	5
IQ - Iraq	5
SN - Senegal	5
MX - Messico	4
OM - Oman	4
PK - Pakistan	4
QA - Qatar	4
TW - Taiwan	4
AR - Argentina	3
AU - Australia	3
CO - Colombia	3
VE - Venezuela	3
AT - Austria	2
CL - Cile	2
EC - Ecuador	2
ID - Indonesia	2
IL - Israele	2
LT - Lituania	2
MY - Malesia	2
NO - Norvegia	2
TT - Trinidad e Tobago	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
EU - Europa	1
GR - Grecia	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LC - Santa Lucia	1
MD - Moldavia	1
MK - Macedonia	1
NP - Nepal	1
PE - Perù	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SI - Slovenia	1
SZ - Regno dello Swaziland	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	3.178

Nome	#
Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer	445
Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6	434
Complexes formed by mutant p53 and their roles in breast cancer	371
A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP	352
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells	301
Tumor Suppressor DAB2IP as a target for post-transcriptional inactivation in cancer	300
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer	291
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP	218
The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells	162
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway	159
Cutting the Brakes on Ras - Cytoplasmic GAPs as Targets of Inactivation in Cancer	148
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications	105
Totale	3.286

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	64	0	0	0	0	0	0	0	0	0	30	17	17
2021/2022	176	10	16	16	10	8	10	9	4	11	16	20	46
2022/2023	216	15	34	21	36	15	33	7	18	24	8	1	4
2023/2024	227	9	19	8	6	20	41	44	43	3	4	23	7
2024/2025	481	11	37	67	60	38	25	19	45	31	65	43	40
2025/2026	827	117	29	50	81	70	78	165	26	93	118	0	0
Totale													3.286

ArTS Archivio della ricerca di Trieste